A Competitive Advantage | The Angulated Screw Channel from Nobel Biocare
Luc and Patrick Rutten are dental laboratory partners and dental technician educators from Belgium. They have been impressed with the Angulated Screw Channel® (ASC) concept from Nobel Biocare.
“The new ASC abutment has changed the way we work,” they say. “The titanium interface is more predictable than the old zirconia connection we used to rely on.
“The ability to offer a cement-free retention option is very important. Lots of dentists prefer screw-retained restorations because of the hazards of cement remnants and the complexity of cementing.
“The ASC concept definitely gives us a competitive advantage.”
The ASC abutment and accompanying Omnigrip™ tooling offer new opportunities for the restoration of implants in the aesthetic zone. The abutment can be placed at an angle of up to 25 degrees anywhere in a 360-degree radius, providing enhanced access even when working in limited space. With no cement necessary, there is also no risk of irritation to the gingival tissue.
For predictable and highly effective implant restorations in more cases, discover the ASC abutment and Omnigrip tooling from Nobel Biocare.
For more information, contact Nobel Biocare on 0208 756 3300 or visit www.nobelbiocare.com
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.